5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively - Publication - Bridge of Knowledge

Your account

login

Search

5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively

Abstract

Citations

  • 3

    CrossRef

  • 0

    Web of Science

  • 2

    Scopus

Authors (10)

  • Photo of dr hab. Daniel Gackowski

    Daniel Gackowski dr hab.

  • Photo of Maciej Gawronski

    Maciej Gawronski

  • Photo of Cassandra Kerr

    Cassandra Kerr

  • Photo of Tomas Radivoyevitch

    Tomas Radivoyevitch

  • Photo of Ewelina Zarakowska

    Ewelina Zarakowska

  • Photo of Marta Starczak

    Marta Starczak

  • Photo of Abdulkadir Abakir

    Abdulkadir Abakir

  • Photo of Alexey Ruzov

    Alexey Ruzov

  • Photo of Jaroslaw Maciejewski

    Jaroslaw Maciejewski

  • Photo of Ryszard Olinski

    Ryszard Olinski

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
Haematologica-The Hematology Journal no. 105, edition 5, pages e213 - e215,
ISSN: 0390-6078
ISSN:
0390-6078
Publication year:
2020
DOI:
Digital Object Identifier (open in new tab) 10.3324/haematol.2019.224030
Verified by:
No verification

seen 105 times

Meta Tags